Related references
Note: Only part of the references are listed.Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
Andre de Lima Guerra Corado et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor
Yu Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
Chemokines and chemokine receptors: an overview
Raffaella Bonecchi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice
Rory R. Koenen et al.
NATURE MEDICINE (2009)
OPINION Chemokine receptor antagonists: overcoming developmental hurdles
Richard Horuk
NATURE REVIEWS DRUG DISCOVERY (2009)
Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
Clarissa E. Vergunst et al.
ARTHRITIS AND RHEUMATISM (2008)
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadiere et al.
CIRCULATION (2008)
Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2(-/-) mice - Evidence for independent chemokine functions in atherogenesis
Noah Saederup et al.
CIRCULATION (2008)
Chemokine Receptor CCR1 Regulates Inflammatory Cell Infiltration after Renal Ischemia-Reperfusion Injury
Kengo Furuichi et al.
JOURNAL OF IMMUNOLOGY (2008)
Chemokines and leukocyte traffic
Federica Sallusto et al.
NATURE IMMUNOLOGY (2008)
Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls
Marceflo Allegretti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)
W. G. Nichols et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2
Alessio Moriconi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Blockade of chemokine signaling in patients with multiple sclerosis
F. Zipp et al.
NEUROLOGY (2006)
Review of progressive multifocal leukoencephalopathy and natalizumab
Allen J. Aksamit
NEUROLOGIST (2006)
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman et al.
ARTHRITIS AND RHEUMATISM (2006)
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis
Ludmila V. Bagaeva et al.
JOURNAL OF IMMUNOLOGY (2006)
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice
RP Gladue et al.
JOURNAL OF IMMUNOLOGY (2006)
Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis
L Revesz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344
CM Brodmerkel et al.
JOURNAL OF IMMUNOLOGY (2005)
MIP-1α-[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-α and LTB4
CDL Ramos et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Proteolytic activation of alternative CCR1 ligands in inflammation
RD Berahovich et al.
JOURNAL OF IMMUNOLOGY (2005)
The toxicology of chemokine inhibition
RW Schroff et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis
MP Quinones et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Dual role of CCR2 during initiation and progression of collagen-induced arthritis:: Evidence for regulatory activity of CCR2+ T cells
H Brühl et al.
JOURNAL OF IMMUNOLOGY (2004)
Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD - A pilot study
DA Mahler et al.
CHEST (2004)
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury
R Bertini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of fractalkine ameliorates murine collagen-induced arthritis
T Nanki et al.
JOURNAL OF IMMUNOLOGY (2004)
Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease
S Eltayeb et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis
JJ Haringman et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
AEI Proudfoot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1
J Onuffer et al.
JOURNAL OF IMMUNOLOGY (2003)
New therapeutics that modulate chemokine networks
MK Schwarz et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates - Inhibitory potential depends on type of injury and leukocytes targeted
C Horvath et al.
CIRCULATION RESEARCH (2002)
Chemokine receptors: Multifaceted therapeutic targets
AEI Proudfoot
NATURE REVIEWS IMMUNOLOGY (2002)
CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin
Y Reiss et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
CCR1+/CCR5+mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis
C Trebst et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Design, synthesis, and discovery of a novel CCR1 antagonist
A Naya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis
DR Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2
L Izikson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1
M Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cutaneous injection of human subjects with macrophage inflammatory protein-1α induces significant recruitment of neutrophils and monocytes
SC Lee et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
